ResearcherGerman Cancer Research CenterNo recent work listed
Michael Orth
Matched on ORCID iD 0000-0002-4608-7151; OpenAlex author ID A5044172388. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2019: 1 paper · 2020: none · 2021: 1 paper
Papers 2
- Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenoc… Co-author DOI 10.1053/j.gastro.2021.05.055↗
- Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Co-author DOI 10.1186/s13014-019-1345-6↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kirsten Lauber · 2 shared papers, 2019–2021 · strength 0.20
- Paper Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality tr… DOI 10.1186/s13014-019-1345-6↗
- Paper Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficie… DOI 10.1053/j.gastro.2021.05.055↗
- Julia V. Mayerle · 2 shared papers, 2019–2021 · strength 0.20
- Paper Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality tr… DOI 10.1186/s13014-019-1345-6↗
- Paper Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficie… DOI 10.1053/j.gastro.2021.05.055↗
- Philipp Metzger · 1 shared paper, 2019 · strength 0.10
- Günter Schneider · 1 shared paper, 2019 · strength 0.10
- Yonggan Xue · 1 shared paper, 2021 · strength 0.10
- Ivonne Regel · 1 shared paper, 2021 · strength 0.10
- Frank Ulrich Weiß · 1 shared paper, 2021 · strength 0.10
- Georg Beyer · 1 shared paper, 2021 · strength 0.10
- Markus M. Lerch · 1 shared paper, 2021 · strength 0.10
- Ujjwal Mukund Mahajan · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.